Come up with a name for your new list and we'll add to it:
VI Technologies raised a round of funding on August 15, 2001. Investors include
Ampersand Capital Partners.
Vitex is developing products designed to improve the safety of the world's blood supply. The Company's proprietary INACTINE technology, currently in a Phase III clinical trial, is designed to inactiva…